Cancer Research UK London Research Institute: Clare Hall Laboratories
153 inventions
IHC
IP
WB
Antigen/Gene or Protein Targets: Maltose binding protein (MBP)
0
reviews
1
reference
1
supplier
Anti-Cul1 [AS97.1]
Invented by Julian Gannon at Cancer Research UK London Research Institute: Clare Hall Laboratories
Anti-XRCC3 [XRCC3 10F1/6]
Invented by Dr Stephen West at Cancer Research UK London Research Institute: Clare Hall Laboratories
Page
1
of
16
148 reagents managed
Anti-HSVUL42 [13C9]
Invented at Cancer Research UK London Research Institute: Clare Hall Laboratories
FACS
IHC
IF
IP
WB
Antigen/Gene or Protein Targets: Herpes Simplex Virus protein UL42 (HSV-UL42)
0
reviews
1
reference
1
supplier
ELISA
IHC
IF
IP
WB
Antigen/Gene or Protein Targets: Herpes Simplex Virus protein UL42 (HSV-UL42)
0
reviews
Add a reference
1
supplier
ELISA
IHC
IP
WB
Antigen/Gene or Protein Targets: Cyclin dependent kinase 1 (Cdk1, cdc2)
0
reviews
12
references
1
supplier
Anti-HSVUL42 [2H4]
Invented at Cancer Research UK London Research Institute: Clare Hall Laboratories
ELISA
IHC
IF
IP
WB
ICC
Antigen/Gene or Protein Targets: Herpes Simplex Virus protein UL42 (HSV-UL42)
0
reviews
6
references
1
supplier
WB
Antigen/Gene or Protein Targets: Cyclin Dependent kinase 1 (Cdk1, Cdc2)
0
reviews
2
references
1
supplier
ELISA
IHC
IP
RIA
WB
Antigen/Gene or Protein Targets: Ruv B protein
0
reviews
4
references
1
supplier
Page
2
of
15